{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:40Z","timestamp":1791357460340,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["2470"],"award-info":[{"award-number":["2470"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40199-019-00257-4","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T21:06:07Z","timestamp":1552683967000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial"],"prefix":"10.1007","volume":"27","author":[{"given":"Ali","family":"Bidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Moazen-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banafsheh","family":"Ghavidel-Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Hassankhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"issue":"9","key":"257_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrrheum.2011.98","volume":"7","author":"T Schmidt-Wilcke","year":"2011","unstructured":"Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011;7(9):518\u201327.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"257_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"257_CR3","first-page":"485","volume":"27","author":"MB Yunus","year":"2000","unstructured":"Yunus MB, Inanici F, Aldag JC, Mangold RF. Fibromyalgia in men: comparison of clinical features with women. J Rheumatol. 2000;27(2):485\u201390.","journal-title":"J Rheumatol"},{"issue":"8","key":"257_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","volume":"18","author":"W H\u00e4user","year":"2014","unstructured":"H\u00e4user W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014;18(8):1052\u20139.","journal-title":"Eur J Pain"},{"issue":"8","key":"257_CR5","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1185\/03007990802288338","volume":"24","author":"C-U Pae","year":"2008","unstructured":"Pae C-U, Luyten P, Marks DM, Han C, Park S-H, Patkar AA, et al. The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin. 2008;24(8):2359\u201371.","journal-title":"Curr Med Res Opin"},{"key":"257_CR6","doi-asserted-by":"publisher","unstructured":"Gracely RH, Ceko M, Bushnell MC. Fibromyalgia and depression. Pain Res Treat. 2012;2012. \n                    https:\/\/doi.org\/10.1155\/2012\/486590\n                    \n                  .","DOI":"10.1155\/2012\/486590"},{"issue":"9","key":"257_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1517\/14728222.2013.818657","volume":"17","author":"M Meeus","year":"2013","unstructured":"Meeus M, Nijs J, Hermans L, Goubert D, Calders P. The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets. 2013;17(9):1081\u20139.","journal-title":"Expert Opin Ther Targets"},{"key":"257_CR8","unstructured":"Cordero MD, de Miguel M, Carmona-L\u00f3pez I, Bonal P, Campa F, Moreno-Fern\u00e1ndez AM. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett. 2010;31(2)."},{"key":"257_CR9","first-page":"741746","volume":"2012","author":"S Becker","year":"2012","unstructured":"Becker S, Schweinhardt P. Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat. 2012;2012:741746.","journal-title":"Pain Res Treat"},{"key":"257_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","volume":"338","author":"KA Sluka","year":"2016","unstructured":"Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114\u201329.","journal-title":"Neuroscience."},{"key":"257_CR11","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.2741\/3598","volume":"14","author":"V Maletic","year":"2009","unstructured":"Maletic V, Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci. 2009;14:5291\u2013338.","journal-title":"Front Biosci"},{"issue":"4","key":"257_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/ijr.14.30","volume":"9","author":"AS Thiagarajah","year":"2014","unstructured":"Thiagarajah AS, Guymer EK, Leech M, Littlejohn GO. The relationship between fibromyalgia, stress and depression. Int J Clin Rheumatol. 2014;9(4):371\u201384.","journal-title":"Int J Clin Rheumatol"},{"issue":"4","key":"257_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11916-016-0556-x","volume":"20","author":"S Chinn","year":"2016","unstructured":"Chinn S, Caldwell W, Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr Pain Headache Rep. 2016;20(4):25.","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"257_CR14","first-page":"513","volume":"8","author":"M Shakiba","year":"2018","unstructured":"Shakiba M, Moazen-Zadeh E, Noorbala AA, Jafarinia M, Divsalar P, Kashani L, et al. Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: a randomized double-blind clinical trial. Avicenna J Phytomed. 2018;8(6):513\u201323.","journal-title":"Avicenna J Phytomed"},{"issue":"2","key":"257_CR15","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3390\/biomedicines5020020","volume":"5","author":"S Kia","year":"2017","unstructured":"Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines. 2017;5(2):E20.","journal-title":"Biomedicines"},{"issue":"5","key":"257_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00296-016-3468-5","volume":"36","author":"YH Lee","year":"2016","unstructured":"Lee YH, Song GG. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials. Rheumatol Int. 2016;36(5):663\u201372.","journal-title":"Rheumatol Int"},{"issue":"6","key":"257_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","volume":"11","author":"W H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010;11(6):505\u201321.","journal-title":"J Pain"},{"issue":"7","key":"257_CR18","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/j.pain.0000000000000558","volume":"157","author":"I Gilron","year":"2016","unstructured":"Gilron I, Chaparro LE, Tu D, Holden RR, Milev R, Towheed T, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016;157(7):1532\u201340.","journal-title":"Pain"},{"issue":"5","key":"257_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600\u201310.","journal-title":"Arthritis Care Res"},{"key":"257_CR20","volume-title":"Manual for the Beck depression inventory-II","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory-II. San Antonio: The Psychological Corporation; 1996."},{"issue":"4","key":"257_CR21","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"257_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware Jr","year":"1996","unstructured":"Ware JE Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"key":"257_CR23","volume-title":"Sf-12: how to score the Sf-12 Physcial and mental health summary scales","author":"JE Ware","year":"1998","unstructured":"Ware JE, Keller SD, Kosinski M. Sf-12: how to score the Sf-12 Physcial and mental health summary scales. Lincoln: QualityMetric Incorporated; 1998."},{"issue":"12","key":"257_CR24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00296-013-2829-6","volume":"33","author":"A Bidari","year":"2013","unstructured":"Bidari A, Hassanzadeh M, Parsa BG, Kianmehr N, Kabir A, Pirhadi S, et al. Validation of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int. 2013;33(12):2999\u20133007.","journal-title":"Rheumatol Int"},{"issue":"4","key":"257_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/da.20070","volume":"21","author":"H Ghassemzadeh","year":"2005","unstructured":"Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck depression inventory-second edition: BDI-II-PERSIAN. Depress Anxiety. 2005;21(4):185\u201392.","journal-title":"Depress Anxiety"},{"issue":"2","key":"257_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00296-013-2929-3","volume":"34","author":"BG Parsa","year":"2014","unstructured":"Parsa BG, Maafi AA, Haghdoost A, Arabi Y, Khojamli M, Chatrnour G, et al. The validity and reliability of the Persian version of the revised fibromyalgia impact questionnaire. Rheumatol Int. 2014;34(2):175\u201380.","journal-title":"Rheumatol Int"},{"issue":"1","key":"257_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2458-9-341","volume":"9","author":"A Montazeri","year":"2009","unstructured":"Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item short form health survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health. 2009;9(1):341.","journal-title":"BMC Public Health"},{"issue":"2","key":"257_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/acr.22111","volume":"66","author":"K Nasser","year":"2014","unstructured":"Nasser K, Kivitz AJ, Maricic MJ, Silver DS, Silverman SL. Twice daily versus once nightly dosing of Pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safety. Arthritis Care Res. 2014;66(2):293\u2013300.","journal-title":"Arthritis Care Res"},{"key":"257_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/CEOR.S66759","volume":"6","author":"JJ Ellis","year":"2014","unstructured":"Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, et al. Impact of potential pregabalin or duloxetine drug\u2013drug interactions on health care costs and utilization among Medicare members with fibromyalgia. Clinicoecon Outcomes Res. 2014;6:389\u2013699.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"8","key":"257_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/pme.12330","volume":"15","author":"SS Johnston","year":"2014","unstructured":"Johnston SS, Udall M, Cappelleri JC, Johnson BH, Shrady G, Chu B-C, et al. Potential drug\u2013drug and drug\u2013condition interactions among fibromyalgia patients initiating Pregabalin or duloxetine: prevalence and health care expenditure impact. Pain Med. 2014;15(8):1282\u201393.","journal-title":"Pain Med"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-019-00257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40199-019-00257-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-019-00257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:27:48Z","timestamp":1584059268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40199-019-00257-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1007\/s40199-019-00257-4","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed were approved by the ethics committee of Iran University of Medical Sciences (code: 25371\u2013109,861) in accordance with the World Medical Association\u2019s code of ethics (Declaration of Helsinki, revised in Brazil 2013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients and if necessary their caregivers. It was clearly explained for the participants that their relationship with the healthcare provider would not be affected should they chose to withdraw from the study at any time.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research data policy"}}]}}